Varicella Zoster Virus ORF9 (VZV VP22) (AA 6-28), (AA 76-100) Protéine

N° du produit ABIN935888

Cette protéine Recombinant Varicella Zoster Virus ORF9 est produite dans Escherichia coli (E. coli).

Aperçu rapide pour Varicella Zoster Virus ORF9 (VZV VP22) (AA 6-28), (AA 76-100) Protéine (ABIN935888)

Antigène: Varicella Zoster Virus ORF9 (VZV VP22)

Type de proteíne: Recombinant

Origine: Varicella Zoster Virus (VZV)

Source: Escherichia coli (E. coli)

Application: Western Blotting (WB), ELISA

Pureté: > 95 % pure

Détail du produit

Attributs du protein: AA 6-28, AA 76-100

Attributs du produit: Purified recombinant VZV ORF9 protein
Expression System: E.coli

Purification: Proprietary chromatographic technique

Information d'application

Indications d'application: Each Investigator should determine their own optimal working dilution for specific applications.

Restrictions: For Research Use only

Stockage

Format: Liquid

Buffer: 25 mM tris-HCl, pH 8.0, with 5 mM EDTA and 50 % glycerol.

Conseil sur la manipulation: Avoid repeated freeze/thaw cycles.

Stock: 4 °C/-20 °C

Stockage commentaire: Store at 4 °C for short term storage. Aliquot and store at -20 °C for long term storage.

Détail du antigène

Antigène: Varicella Zoster Virus ORF9 (VZV VP22)

Classe de substances: Viral Protein

Sujet: VZV is closely related to the herpes simplex viruses (HSV), sharing much genomehomology. The known envelope glycoproteins (gB, gC, gE, gH, gI, gK, gL) correspond with those in HSV, however there is no equivalent of HSV gD. VZV virons are spherical and 150-200 nm in diameter. Their lipidenvelope encloses the nucleocapsid of 162 capsomeres arranged in a hexagonalform. Its DNAis a single, linear, double-stranded molecule, 125,000 nt long. The virus is very susceptible to disinfectants, notably sodium hypochlorite. Within the body it can be treated by a number of drugs and therapeutic agents including aciclovir, zoster-immune globulin (ZIG), and vidarabine.
Alternative Names: Varicella Zoster Virus ORF9 protein